BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11429647)

  • 1. Oxytocin antagonists: clinical and scientific considerations.
    Thornton S; Vatish M; Slater D
    Exp Physiol; 2001 Mar; 86(2):297-302. PubMed ID: 11429647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of preterm labor with the oxytocin and vasopressin antagonist Atosiban.
    Bossmar T
    J Perinat Med; 1998; 26(6):458-65. PubMed ID: 10224602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atosiban.
    Shubert PJ
    Clin Obstet Gynecol; 1995 Dec; 38(4):722-4. PubMed ID: 8616970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxytocin receptor antagonists for inhibiting preterm labour.
    Flenady V; Reinebrant HE; Liley HG; Tambimuttu EG; Papatsonis DN
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD004452. PubMed ID: 24903678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group.
    Valenzuela GJ; Sanchez-Ramos L; Romero R; Silver HM; Koltun WD; Millar L; Hobbins J; Rayburn W; Shangold G; Wang J; Smith J; Creasy GW
    Am J Obstet Gynecol; 2000 May; 182(5):1184-90. PubMed ID: 10819856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experience of using oxytocin antagonist atosiban in the rescue therapy of preterm labour].
    Tan JP; Chen H; Du BJ; Liu YL; Wang YH; Zhang JP
    Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):81-4. PubMed ID: 18683742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxytocin, its antagonist Atosiban, and preterm labor: a role for placental nitric oxide.
    Nanetti L; Raffaelli F; Giulietti A; Sforza G; Raffaele Giannubilo S; Ciavattini A; Tranquilli AL; Mazzanti L; Vignini A
    J Matern Fetal Neonatal Med; 2015 Mar; 28(5):611-6. PubMed ID: 24920283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxytocin receptor antagonists for inhibiting preterm labour.
    Papatsonis D; Flenady V; Cole S; Liley H
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004452. PubMed ID: 16034931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol.
    French/Australian Atosiban Investigators Group
    Eur J Obstet Gynecol Reprod Biol; 2001 Oct; 98(2):177-85. PubMed ID: 11574128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging tocolytics for maintenance therapy of preterm labour: oxytocin antagonists and calcium channel blockers.
    Kim A; Shim JY
    BJOG; 2006 Dec; 113 Suppl 3():113-5. PubMed ID: 17206978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue.
    Romero R; Sibai BM; Sanchez-Ramos L; Valenzuela GJ; Veille JC; Tabor B; Perry KG; Varner M; Goodwin TM; Lane R; Smith J; Shangold G; Creasy GW
    Am J Obstet Gynecol; 2000 May; 182(5):1173-83. PubMed ID: 10819855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.
    European Atosiban Study Group
    Acta Obstet Gynecol Scand; 2001 May; 80(5):413-22. PubMed ID: 11328217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea.
    Akerlund M; Melin P; Maggi M
    Adv Exp Med Biol; 1995; 395():595-600. PubMed ID: 8714023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytocin antagonists for tocolysis in preterm labour -- a systematic review.
    Coomarasamy A; Knox EM; Gee H; Khan KS
    Med Sci Monit; 2002 Nov; 8(11):RA268-73. PubMed ID: 12444392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxytocin and fetal membranes in preterm labor: current concepts and clinical implication.
    Laudanski T; Pierzynski P
    Gynecol Endocrinol; 2003 Jun; 17(3):261-7. PubMed ID: 12857435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour.
    Nisell H; Wolff K
    BJOG; 2003 Jan; 110(1):89. PubMed ID: 12504956
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomized trial of oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of spontaneous preterm labor in Taiwanese women.
    Lin CH; Lin SY; Shyu MK; Chen SU; Lee CN
    J Formos Med Assoc; 2009 Jun; 108(6):493-501. PubMed ID: 19515630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and clinical experience with the new evidence-based tocolytic atosiban.
    Husslein P
    Acta Obstet Gynecol Scand; 2002 Jul; 81(7):633-41. PubMed ID: 12190838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxytocin antagonists for the management of preterm birth: a review.
    Usta IM; Khalil A; Nassar AH
    Am J Perinatol; 2011 Jun; 28(6):449-60. PubMed ID: 21170825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The choice of a tocolytic for the treatment of preterm labor: a critical evaluation of nifedipine versus atosiban.
    Lyndrup J; Lamont RF
    Expert Opin Investig Drugs; 2007 Jun; 16(6):843-53. PubMed ID: 17501696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.